A. Tejerina
Impact in
-
- Breast Cancer Treatment Studies
-
- Cancer Cells and Metastasis
- Drug Transport and Resistance Mechanisms
- HER2/EGFR in Cancer Research
- Neutropenia and Cancer Infections
Papers in
-
- Breast Cancer Treatment Studies 6
- Protease and Inhibitor Mechanisms 2
- Oncology 8
- HER2/EGFR in Cancer Research 3
- Drug Transport and Resistance Mechanisms 2
- Co-authors
- J. Schneider (18 shared papers)Fernando Martínez‐Arribas (7 shared papers)Marina Pollán (3 shared papers)Miguel Martín (2 shared papers)Á. Ruibal (13 shared papers)Álvaro Ruibal (2 shared papers)José Ignacio Arias (10 shared papers)Severino González-Roces (1 shared paper)
- Journals
- Breast Cancer Research (2 papers)The International Journal of Biological Markers (2 papers)British journal of surgery (1 paper)PLoS ONE (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- SpainUnited StatesVenezuela
In The Last Decade
A. Tejerina
29 papers receiving 385 citations
Peers
Comparison fields: 5 of 56
- Cancer Research 99
- Oncology 172
- Pharmacology 30
- Immunology and Allergy 11
- Genetics 44
Countries citing papers authored by A. Tejerina
This map shows the geographic impact of A. Tejerina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Tejerina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Tejerina more than expected).
Fields of papers citing papers by A. Tejerina
This network shows the impact of papers produced by A. Tejerina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Tejerina. The network helps show where A. Tejerina may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Tejerina, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 48 | |
| 2 | Modulation of molecular marker expression by induction chemotherapy in locally advanced breast cancer: correlation with the response to therapy and the expression of MDR1 and LRP. | 2001 | 43 |
| 3 | 2001 | 43 | |
| 4 | 2013 | 37 | |
| 5 | Bcl-2 expression in breast cancer: a comparative study at the mRNA and protein level. | 2007 | 35 |
| 6 | 2010 | 30 | |
| 7 | 1999 | 28 | |
| 8 | 2003 | 26 | |
| 9 | Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases. | 2002 | 22 |
| 10 | 2001 | 20 | |
| 11 | Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients. | 2003 | 18 |
| 12 | Bax expression in untreated breast cancer: an immunocytometric study of 255 cases. | 2008 | 8 |
| 13 | 2013 | 8 | |
| 14 | Cellular accumulation of uPA-PAI-1 [correction of UPA-PAI-1] and uPA-PAI-2 [correction of UPA-PAI-2] complexes in early (pT1) breast cancer: a new link in the uPA-UPAr-PAI chain. | 2000 | 5 |
| 15 | Proliferation measurement in breast cancer by two different methods. | 2006 | 5 |
| 16 | [Clinical-biological differences between invasive ductal carcinomas and breast lobular carcinomas. Preliminary results]. | 1999 | 5 |
| 17 | 2000 | 5 | |
| 18 | 2005 | 4 | |
| 19 | Molecular subgroups of small (pT1) breast carcinomas belonging exclusively to the ductal infiltrating variety. | 2008 | 4 |
| 20 | 2013 | 3 |
About A. Tejerina
A. Tejerina is a scholar working on Cancer Research, Oncology, Cell Biology, Genetics and Molecular Biology, having authored 33 papers that have together received 412 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Proteoglycans and glycosaminoglycans research (4 papers), HER2/EGFR in Cancer Research (3 papers), Estrogen and related hormone effects (2 papers), Glycosylation and Glycoproteins Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Cell Adhesion Molecules Research (2 papers) and Protease and Inhibitor Mechanisms (2 papers). The work is most often cited by research in Cancer Research (99 citations), Oncology (172 citations), Pharmacology (30 citations), Immunology and Allergy (11 citations) and Genetics (44 citations). A. Tejerina has collaborated with scholars based in Spain, United States and Venezuela. Frequent co-authors include J. Schneider, Fernando Martínez‐Arribas, Marina Pollán, Miguel Martín, Á. Ruibal, Álvaro Ruibal, José Ignacio Arias, Severino González-Roces, Ana Fernández‐Santander and Margarita Rubio Alonso. Their work appears in journals such as Breast Cancer Research, The International Journal of Biological Markers, British journal of surgery, PLoS ONE and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.